Jonsson Comprehensive Cancer Center
🇺🇸United States
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Phase 2
Recruiting
- Conditions
- Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- Interventions
- Procedure: Computed TomographyOther: Gallium Ga 68 GozetotideProcedure: Positron Emission TomographyProcedure: PSMA PET ScanOther: Questionnaire AdministrationProcedure: Single Photon Emission Computed Tomography
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT06216249
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
Phase 2
Recruiting
- Conditions
- Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Early Stage Breast Carcinoma
- Interventions
- Procedure: Biospecimen CollectionOther: Educational InterventionOther: Exercise InterventionOther: Physical Performance TestingDrug: Placebo AdministrationOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 164
- Registration Number
- NCT06113016
- Locations
- 🇺🇸
UCLA Health Cancer Care in Alhambra, Alhambra, California, United States
🇺🇸UCLA Health Beverly Hills Primary & Specialty Care, Beverly Hills, California, United States
🇺🇸UCLA Health Burbank Primary & Specialty Care, Burbank, California, United States
Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer
Not Applicable
Active, not recruiting
- Conditions
- Stage III Pancreatic CancerPancreatic Adenocarcinoma Non-resectable
- Interventions
- Other: Dietary InterventionOther: Best PracticeOther: Medical Chart ReviewOther: Medical Device Usage and EvaluationOther: Nutritional AssessmentOther: Questionnaire Administration
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06090916
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups
Not Applicable
Active, not recruiting
- Conditions
- Colorectal Carcinoma
- Interventions
- Other: Best PracticeOther: ConsultationOther: Electronic Health Record ReviewOther: Educational InterventionOther: Fecal Immunochemical TestBehavioral: FeedbackBehavioral: Health EducationOther: Support Education ActivityOther: Text Message-Based Navigation Intervention
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 9745
- Registration Number
- NCT06090643
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
Early Phase 1
Completed
- Conditions
- Malignant Breast NeoplasmBenign Breast NeoplasmBreast Carcinoma
- Interventions
- Procedure: Diffusion Weighted ImagingProcedure: Magnetic Resonance Spectroscopic Imaging
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 83
- Registration Number
- NCT06090630
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
Not Applicable
Recruiting
- Conditions
- GlioblastomaRecurrent GlioblastomaResectable Glioblastoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Magnetic Resonance ImagingOther: Medical Chart Review
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06090903
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Psychoeducation for Uveal Melanoma
Not Applicable
Active, not recruiting
- Conditions
- Uveal Melanoma
- Interventions
- Behavioral: Education for InterventionBehavioral: Best Practice
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 108
- Registration Number
- NCT06075589
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial
Phase 2
Recruiting
- Conditions
- Prostate AdenocarcinomaStage II Prostate Cancer AJCC V8Stage IIIA Prostate Cancer AJCC V8Stage IIIB Prostate Cancer AJCC V8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyOther: Gallium Ga 68 GozetotideRadiation: Guided Stereotactic Body Radiation TherapyProcedure: Multiparametric Magnetic Resonance ImagingProcedure: Positron Emission TomographyOther: Questionnaire Administration
- First Posted Date
- 2023-10-04
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 95
- Registration Number
- NCT06067269
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
Recruiting
- Conditions
- Osteosarcoma
- Interventions
- Other: standard of care biopsy
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT06064682
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
Phase 1
Recruiting
- Conditions
- Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
- Interventions
- Diagnostic Test: pH Measurement of in vivo tissue
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06059690
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States